Skip to main content
Clinical Trials/NCT00488501
NCT00488501
Completed
Not Applicable

Clinical Usefulness and Efficacy of Intrathoracic Impedance Monitoring Using the OptiVol Patient Alert(TM) in Medtronic(R) ICD's for Early Detection of Decompensated Heart Failure

Catharina Ziekenhuis Eindhoven1 site in 1 country29 target enrollmentJuly 2007
ConditionsHeart Failure

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure
Sponsor
Catharina Ziekenhuis Eindhoven
Enrollment
29
Locations
1
Primary Endpoint
clinical efficacy and value of ambulatory intrathoracic impedance measurement of the Optivol alert as an indicator of decompensated heart failure reflected by sensitivity and positive predictive value
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

In this study we investigate the clinical value and efficacy of OptiVol (TM) impedance measurements by Medtronic (R) ICD's. We aim to determine sensitivity and positive predictive value for detecting heart failure. We also investigate if left ventricular filling pattern measured by echocardiography and/or brain natriuretic peptide (BNP) level can be used to improve the positive predictive value of the Optivol alert

Detailed Description

Patients who have a Medtronic (R) ICD equipped with the Optivol (TM) impedance monitoring will be included in your study after informed consent. The OptiVol (TM) feature will be activated and at baseline data is collected (blood sample including BNP, electrocardiography, echocardiography, chest X-ray and ICD check-up). During follow-up patients will be re-assessed in case of an OptiVol alert or in case of heart failure.

Registry
clinicaltrials.gov
Start Date
July 2007
End Date
January 2009
Last Updated
16 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Catharina Ziekenhuis Eindhoven

Eligibility Criteria

Inclusion Criteria

  • chronic heart failure of any cause
  • implanted Medtronic ICD with OptiVol impedance monitoring

Exclusion Criteria

  • inability to receive informed consent

Outcomes

Primary Outcomes

clinical efficacy and value of ambulatory intrathoracic impedance measurement of the Optivol alert as an indicator of decompensated heart failure reflected by sensitivity and positive predictive value

Time Frame: end of follow-up

Secondary Outcomes

  • influence of left ventricular filling pattern and brain natriuretic level on the positive predictive value of the Optivol alert(end of follow-up)

Study Sites (1)

Loading locations...

Similar Trials